http://www.eanm.org/publications/guidelines/
http://www.eanm.org/esmit/level-1/
http://www.zdravlje.gov.rs/showpage.php?id=145
Vodić za dijagnostikovanje i lečenje tiroidnih nodusa i diferentovanog tiroidnog karcinoma
EU legislation. Basic safety standards and Council Directive 59/2013. Instrumentation in nuclear medicine. Standard gamma camera, SPECT and PET.
Static and dynamic and tomographic investigation in nuclear medicine. Acquainting with the basis of the acquisition and processing of the static, dynamic and tomographic studies.
Basis of hybrid imaging: PET-CT, SPECT-CT, PET-MRI .
/Acceptance Testing for Nuclear Medicine Instrumentation (2010); Routine Quality Control Recommendations for Nuclear Medicine Instrumentation (2010); Curriculum for education and training of Medical Physicists in Nuclear Medicine. EANM and EFOMP Recommendations (2015) /
Investigations of the disorders of endocrine system.
Thyroid scintigraphy. Radiopharmaceuticals.
Parathyroid scintigraphy. /EANM parathyroid guidelines (2009)/. Intraoperative detection of parathyroid.
NET scintigraphy with radiolabeled somatostatine analogues. /EANM guidelines on 111In-Pentetreotide Scintigraphy (2010)/
Scintigraphy of cortex and medulla of suprarenal glands and tumors of chromafine tissue. /Guideline for Radioiodinated MIBG Scintigraphy in Children (2002); EANM 2012 Guidelines for Radionuclide Imaging of Phaeochromocytoma and Paraganglioma (2012);/
Investigation of musculoskeletal disorders.
Bone scintigraphy in musculoskeletal diseases. /EANM Guidelines for Bone Scintigraphy in Children (2010);/The EANM practice guidelines for Bone Scintigraphy (2016);/
NET scintigraphy with radiolabeled somatostatine analogues. /EANM guidelines on 111In-Pentetreotide Scintigraphy (2010)/
Scintigraphy of cortex and medulla of suprarenal glands and tumors of chromafine tissue. /Guideline for Radioiodinated MIBG Scintigraphy in Children (2002); EANM 2012 Guidelines for Radionuclide Imaging of Phaeochromocytoma and Paraganglioma (2012);/
Investigation of musculoskeletal disorders.
Bone scintigraphy in musculoskeletal diseases. /EANM Guidelines for Bone Scintigraphy in Children (2010);/The EANM practice guidelines for Bone Scintigraphy (2016);/
EU regulations. Nuclear medicine in laboratory diagnostics. Antigen – Antibody reactions in laboratory diagnostics.
Nuclear medicine in gastroenterohepatology. Functional, morphological and hemodynamic investigations of the liver, pancreas, spleen and digestive system. Scintigraphic methods in the liver investigation. Demonstration of the characteristic liver scintigrams. Functional investigation in gastroenterology. Biliary system.Hepatobiliary scintigraphy. Cholecystoscintigraphy.
Scintigraphy of parotide glands. Quantitative scintigraphic methods (esophageal transit, gastric emptying, gastroesophageal reflux, engerogastric reflux). Gastrointestinal bleding, Meckel’s divertikulum. /SNMMI Procedure Standard/EANM Practice Guideline for Gastrointestinal Bleeding Scintigraphy 2.0 (2014); The SNMMI and EANM Practice Guideline for Small-Bowel and Colon Transit (2013)/
Nuclear medicine in infection and inflammation. Visualization nuclear medicine methods in detection of infection and inflammation. /EANM guidelines for Labelling of Leukocytes with 111In-Oxine (2010); EANM guidelines for Labelling of Leukocytes with 99mTc-HMPAO (2010); EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection (2013)/
Specific radiopharmaceuticals and mechanisms of their accumulation in the inflammatory and infective lesions. Scintigraphic investigations of infection and inflammation: demonstration of results.
Radionuclide therapy. /EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds (2011); EANM procedure guidelines for therapy of benign thyroid disease (2010); EANM procedure guideline for treatment of refractory metastatic bone pain (2008); Guidelines for radioiodine therapy of differentiated thyroid cancer (2008); EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases (2007); EANM Procedure Guidelines for Radiosynovectomy (2002); Guidelines for 131I – ethiodised oil [Lipiodol] Therapy (2002)/.
Radionuclide therapy. Therapy of neuroendocrine tumors. Therapeutical application of 131 J-MJBG, radiolabeled somatostatine analogues, radioimmunotherapy). /EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin) (2006); EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy (2008);/
PET in tumors of dygestive system and abdomen. Tumors of esophagus, gaster, small and large intenstines, liver, bile ducts, pancreas, demonstration of the typical cases.
PET in evaluation of the pelvic tumors. Demonstration of the typical cases.
PET in evaluation of endocrine and neuroendocrine tumors. Radiopharmaceuticals, indications, demonstration of clinical cases. /EANM procedure guidelines for PET/CT tumour imaging with 686a-DOTA-conjugated peptides (2010);/
PET in musculoskeletal diseases. /EANM guidelines /sodium 18F-fluoride with PET/CT bone scans (2010);/
Introduction in nuclear medicine, history – European Association of Nuclear Medicine (EANM). EANM gudielines. EU legislation. Radioactive isotopes as biological markers. Physiological basis of application of radiopharmaceuticals in nuclear medicine. /Guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) (2014); The SNMMI and EANM Practice Guideline for Tele-Nuclear Medicine 2.0 (2014); EANM/SNMMI Guideline for Guideline Development 6.0 (2012)/.
EU legislation. Basic safety standards and Council Directive 59/2013. Basic principles of protection from opened radiation sources. Basics of compartmental analysis and kynetics of isotopes. / EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases (2013); EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases (Supplement) (2013); EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting (2010); EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy (2008)/.
EU legislation. Basic safety standards and Council Directive 59/2013. Cyclotron. Radionuclides/positron emitters in investigations of metabolic and pathophysiological mechanisms. /Guidelines on current good Radiopharmacy Practice (cGRPP) for the small-scale preparations of radiopharmaceuticals (2010); Guidelines on current good Radiopharmacy Practice (cGRPP) in the Preparation of Radiopharmaceuticals (2007)/.
Investigations of the disorders of central nervous system. / Brain Neurotransmission SPET using 123I-labelled Dopamine D2 Receptor Ligands (2009); Brain Neurotransmission SPET using 123I-labelled Dopamine Transporter Ligands (2009); Brain Perfusion SPET using 99mTc-labelled Radiopharmaceutical (2009); Procedure Guidelines for Brain Tumour Imaging using Labelled Amino Acid Analogues (2006) /.
Nuclear medicine in cardiology. Hemodynamic, functional and morphological investigations of the heart. /EANM/ESR/ECNC Hybrid cardiac imaging: SPECT/CT and PET/CT (2011); EANM/ESC guidelines for radionuclide imaging of cardiac function (2008); EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology (2005)/ Radionuclide ventriculography and perfusion myocardial scintigraphy. Demonstration of typical cases of perfusion myocardial scintigraphy./EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT (2015);/
Nuclear medicine in pulmonology. Perfusion and ventilation lung investigations. Perfusion and ventilation lung scintigraphy. Guidelines for Lung Scintigraphy in Children (2007) ; EANM guidelines for ventilation / perfusion scintigraphy – Part 1 (2009);
Demonstration of perfusion and ventilation scintigrams./ EANM guidelines for ventilation / perfusion scintigraphy – Part 2 (2009);/
Investigation of nephrourological disorders. Application of nuclear medicine in pediatrics. /Guidelines for standard and diuretic renogram in children (2011); Guidelines for Direct Radionuclide Cystography in Children (2002); Guidelines for Glomerular Filtration Rate Determination in Children (2000); Guidelines for Indirect Radionuclide Cystography (2000); Guidelines for Standard and Diuretic Renogram in Children (2000); Guidelines on 99mTc-DMSA Scintigraphy in Children (2009) /
Investigation of hematological disorders. Laboratory hematology./ EANM Bone Marrow Dosimetry Guidelines (2010);/
Nuclear medicine methods in oncology. /EANM-EORTC general recommendations for sentinel node diagnostics in melanoma (2009); Sentinel node in breast cancer procedural guidelines (2007); Breast Scintigraphy (2003); Breast scintigraphy with breast specific gamma cameras 1.0 (2010)/ Specific radiopharmaceuticals and nuclear medicine methods in oncology. Basic and clinical aspects immunoscintigraphy and radioimmunotherapy.
Molecular investigations. Oncological investigations.
Tumorotropic radiopharmaceuticals and visualization techniques. Intraoperative tumor detection. Therapeutic application of nuclear medicine in oncology. / EANM-SENT Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma (2009); EANM/SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer (2013)/
Introduction in nuclear medicine, history – European Association of Nuclear Medicine (EANM). EANM gudielines. EU legislation. Radioactive isotopes as biological markers. Physiological basis of application of radiopharmaceuticals in nuclear medicine. /Guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD) (2014); The SNMMI and EANM Practice Guideline for Tele-Nuclear Medicine 2.0 (2014); EANM/SNMMI Guideline for Guideline Development 6.0 (2012)/.
EU legislation. Basic safety standards and Council Directive 59/2013. Basic principles of protection from opened radiation sources. Basics of compartmental analysis and kynetics of isotopes. / EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases (2013); EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases (Supplement) (2013); EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting (2010); EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy (2008)/.
EU legislation. Basic safety standards and Council Directive 59/2013. Cyclotron. Radionuclides/positron emitters in investigations of metabolic and pathophysiological mechanisms. /Guidelines on current good Radiopharmacy Practice (cGRPP) for the small-scale preparations of radiopharmaceuticals (2010); Guidelines on current good Radiopharmacy Practice (cGRPP) in the Preparation of Radiopharmaceuticals (2007)/.
Investigations of the disorders of central nervous system. / Brain Neurotransmission SPET using 123I-labelled Dopamine D2 Receptor Ligands (2009); Brain Neurotransmission SPET using 123I-labelled Dopamine Transporter Ligands (2009); Brain Perfusion SPET using 99mTc-labelled Radiopharmaceutical (2009); Procedure Guidelines for Brain Tumour Imaging using Labelled Amino Acid Analogues (2006) /.
Nuclear medicine in cardiology. Hemodynamic, functional and morphological investigations of the heart. /EANM/ESR/ECNC Hybrid cardiac imaging: SPECT/CT and PET/CT (2011); EANM/ESC guidelines for radionuclide imaging of cardiac function (2008); EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology (2005)/
Radionuclide ventriculography and perfusion myocardial scintigraphy. Demonstration of typical cases of perfusion myocardial scintigraphy./EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT (2015);/
Nuclear medicine in pulmonology. Perfusion and ventilation lung investigations. Perfusion and ventilation lung scintigraphy. Guidelines for Lung Scintigraphy in Children (2007) ; EANM guidelines for ventilation / perfusion scintigraphy – Part 1 (2009);
Demonstration of perfusion and ventilation scintigrams./ EANM guidelines for ventilation / perfusion scintigraphy – Part 2 (2009);/
Investigation of nephrourological disorders. Application of nuclear medicine in pediatrics. /Guidelines for standard and diuretic renogram in children (2011); Guidelines for Direct Radionuclide Cystography in Children (2002); Guidelines for Glomerular Filtration Rate Determination in Children (2000); Guidelines for Indirect Radionuclide Cystography (2000); Guidelines for Standard and Diuretic Renogram in Children (2000); Guidelines on 99mTc-DMSA Scintigraphy in Children (2009) /
Investigation of hematological disorders. Laboratory hematology./ EANM Bone Marrow Dosimetry Guidelines (2010);/
Nuclear medicine methods in oncology. /EANM-EORTC general recommendations for sentinel node diagnostics in melanoma (2009); Sentinel node in breast cancer procedural guidelines (2007); Breast Scintigraphy (2003); Breast scintigraphy with breast specific gamma cameras 1.0 (2010)/
Specific radiopharmaceuticals and nuclear medicine methods in oncology. Basic and clinical aspects immunoscintigraphy and radioimmunotherapy.
Molecular investigations. Oncological investigations.
Tumorotropic radiopharmaceuticals and visualization techniques. Intraoperative tumor detection. Therapeutic application of nuclear medicine in oncology. / EANM-SENT Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma (2009); EANM/SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer (2013)/
Nuclear medicine methods in detection and staging of tumors of lung and mediastinum.
Somatostatine analogues in diagnosis and follow up of lung tumors.
PET in oncology . /EANM integration of FDG-PET/CT into external beam radiation therapy planning (2012); PET in Radiotherapy Planning (2010); FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 (2015)/. General indications for PET/CT in clinical practice.
PET in lung tumors. Application in surgical ind internal medicine practice and case reports. PET in cardilogy. Radiopharmaceuticals, indications in clinical practice and deminstration of the typical cases.
PET in head and neck tumors. Radiopharmaceuticals, aplication in clinical practice. /Brain Imaging using [18F]FDG (2009); SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 (2016)/
PET in evaluation of lymphomas. Application in hematology and demonstration of typical cases. PET in breast tumors. Application in clinical practice.